INLECITUG
UNII FA5YAU8H6R

Substance Identification & Data

This profile provides standardized clinical and technical data for Inlecitug, uniquely identified by the FDA Unique Ingredient Identifier (UNII) FA5YAU8H6R.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2997627-68-4 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
FA5YAU8H6R
CAS Registry Number
2997627-68-4
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
INLECITUG
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
C216036
National Cancer Institute reference terminology for clinical and research data.
INN ID
13399
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Inlecitug. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

INLECITUG

Common Names & Synonyms

H-GAMMA1 HEAVY CHAIN CHIMERIC (1-447) (VH (MUS MUSCULUS IGHV14-4*02 (91.8%) -(IGHD) -IGHJ4*01 (91.7%) S123>T (112), CDR-IMGT (8.8.10) (26-33.51-58.97-106)) (1-117) -HOMO SAPIENS IGHG1*01 (100%) G1M17,1 CH1 K120, CH3 D12, L14 (CH1 K120 (214) (118-215), HINGE 1-15 (216-230), CH2 (231-340), CH3 D12 (356), L14 (358) (341-445), CHS (446-447)) (118-447)), (220-213')-DISULFIDE WITH L-KAPPA LIGHT CHAIN CHIMERIC (1'-213') (V-KAPPA (MUS MUSCULUS IGKV4-57*01 (98.9%) -IGKJ4*01 (100%), CDR-IMGT (5.3.9) (27'-31'.49'-51'.88'-96')) (1'-106') -HOMO SAPIENS IGKC*01 (100%) KM3 A45.1, V101 (C-KAPPA A45.1 (152'), V101 (190')) (107'-213')); DIMER (226-226'':229-229'')-BISDISULFIDE, PRODUCED IN CHINESE HAMSTER OVARY (CHO) CELLS, CELL LINE CHO-DG44, GLYCOFORM ALFA
IMMUNOGLOBULIN G1, ANTI-(HUMAN VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2) (HUMAN MONOCLONAL GENSCI043 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL GENSCI043 .KAPPA.-CHAIN, DIMER
IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS KDR (KINASE INSERT DOMAIN RECEPTOR, VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2, VEGFR2, VEGF-R2, FLK1, CD309)), CHIMERIC MONOCLONAL ANTIBODY
INLECITUG [INN]

External Clinical & Regulatory Resources

CAS
Common Chemistry
NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record
NIH
NCI Thesaurus